Product Information
FINGOLIMOD 0.5 MG CAPSULE is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $3.2890 per EA under NDC 68462016630. Its NADAC has been published 145 times since Sep 20, 2023.
Strength
.5 mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462016630
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
FINGOLIMOD HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA207985On Market Since
9/28/2022
Pharmacological Classes
Price Statistics
The NADAC for FINGOLIMOD 0.5 MG CAPSULE has been published 145 times since Sep 20, 2023, and over the history we have for it it has declined 66.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.2890 per EA |
|---|---|
| All-time high | $10.0429 (May 15, 2024) |
| All-time low | $3.2890 (Jun 17, 2026) |
| 52-week high | $5.7374 |
| 52-week low | $3.2890 |
| Median price | $7.7302 |
| Average price | $7.3269 |
| Largest weekly change | +16.8% (Jul 17, 2024) |
| Weeks tracked | 145 |
| Tracking since | Sep 20, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the fingolimod market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of FINGOLIMOD 0.5 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for FINGOLIMOD 0.5 MG CAPSULE, manufactured by Glenmark Pharmaceuticals Inc., USA, is $3.2890 per EA (NDC 68462016630), effective Jun 24, 2026.
How has the price of FINGOLIMOD 0.5 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for FINGOLIMOD 0.5 MG CAPSULE has declined 66.2%. It has been tracked across 145 weekly CMS publications since Sep 20, 2023.
What are the highest and lowest recorded NADAC prices for FINGOLIMOD 0.5 MG CAPSULE?
Since Sep 20, 2023, the NADAC for FINGOLIMOD 0.5 MG CAPSULE has ranged from a low of $3.2890 (Jun 17, 2026) to a high of $10.0429 (May 15, 2024), with a median of $7.7302 per EA.
Are there cheaper alternatives to FINGOLIMOD 0.5 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of FINGOLIMOD 0.5 MG CAPSULE, so no direct lower-cost alternative is listed.
Who manufactures FINGOLIMOD 0.5 MG CAPSULE?
FINGOLIMOD 0.5 MG CAPSULE (NDC 68462016630) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.
Related Drugs
Same classification